Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy

Cardiology Division, Stanford University School of Medicine, California.

The continuous wave Doppler ultrasound signal across the left ventricular outflow tract in hypertrophic cardiomyopathy has a characteristic pattern that is in keeping with the dynamic nature of the pressure gradient in this condition. To determine the accuracy and reliability of the peak Doppler flow velocity signal for measuring the peak pressure gradient in this condition, 340 beats were analyzed from five consecutive patients studied with simultaneous continuous wave Doppler ultrasound and dual catheter pressure recordings across the left ventricular outflow tract. Each patient was studied at steady state and during physiologic and pharmacologic manipulations of the pressure gradient. Peak velocity and calculated peak gradient were determined by two independent observers who did not know the catheter measurements. In addition, 18 beats with well defined flow velocity envelopes were digitized for analysis of the magnitude, timing and contour of the instantaneous Doppler ultrasound and catheter gradients throughout systole. Peak catheter gradient in the 340 beats ranged from 12 to 245 mm Hg. The correlations between the Doppler-derived and catheter peak gradients were close (r = 0.96, SEE = 4 mm Hg for Observer 1 and r = 0.97, SEE = 11 mm Hg for Observer 2). Interobserver variability for measurement of peak flow velocity was small (mean +/- SD 0.16 +/- 0.15 m/s). An interobserver difference greater than 0.3 m/s occurred in 25 of the 340 beats analyzed. By retrospective analysis, this was due to contamination of the outflow tract signal by mitral regurgitation.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				D H Kwon, R M Setser, M Thamilarasan, Z V Popovic, N G Smedira, P Schoenhagen, M J Garcia, H M Lever, and M Y Desai Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy Heart, October 1, 2008; 94(10): 1295 - 1301. [Abstract] [Full Text] [PDF]

				R. K. Kaple, R. T. Murphy, L. M. DiPaola, P. L. Houghtaling, H. M. Lever, B. W. Lytle, E. H. Blackstone, and N. G. Smedira Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes Ann. Thorac. Surg., May 1, 2008; 85(5): 1527 - 1535. [Abstract] [Full Text] [PDF]

				O. I I Soliman, P. Knaapen, M. L Geleijnse, P. A Dijkmans, A. M Anwar, A. Nemes, M. Michels, W. B Vletter, A. A Lammertsma, and F. J ten Cate Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography Heart, October 1, 2007; 93(10): 1204 - 1212. [Abstract] [Full Text] [PDF]

				I. Barac, S. Upadya, R. Pilchik, G. Winson, M. Passick, F. A. Chaudhry, and M. V. Sherrid Effect of Obstruction on Longitudinal Left Ventricular Shortening in Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., March 20, 2007; 49(11): 1203 - 1211. [Abstract] [Full Text] [PDF]

				T. Matsuki, K. Isoda, R. Horai, A. Nakajima, Y. Aizawa, K. Suzuki, F. Ohsuzu, and Y. Iwakura Involvement of Tumor Necrosis Factor-{alpha} in the Development of T Cell-Dependent Aortitis in Interleukin-1 Receptor Antagonist-Deficient Mice Circulation, August 30, 2005; 112(9): 1323 - 1331. [Abstract] [Full Text] [PDF]

				A. Woo, W. G. Williams, R. Choi, E. D. Wigle, E. Rozenblyum, K. Fedwick, S. Siu, A. Ralph-Edwards, and H. Rakowski Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy Circulation, April 26, 2005; 111(16): 2033 - 2041. [Abstract] [Full Text] [PDF]

				M. V. Sherrid, I. Barac, W. J. McKenna, P. M. Elliott, S. Dickie, L. Chojnowska, S. Casey, and B. J. Maron Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1251 - 1258. [Abstract] [Full Text] [PDF]

				M. Hamada, Y. Shigematsu, K. Ohshima, J. Suzuki, A. Ogimoto, T. Ohtsuka, and Y. Hara Diagnostic Usefulness of Carotid Pulse Tracing in Patients With Hypertrophic Obstructive Cardiomyopathy Due to Midventricular Obstruction: A Comparison With Idiopathic Hypertrophic Subaortic Stenosis Chest, October 1, 2003; 124(4): 1275 - 1283. [Abstract] [Full Text] [PDF]

				J. X. Qin, T. Shiota, H. M. Lever, D. N. Rubin, F. Bauer, Y. J. Kim, M. Sitges, N. L. Greenberg, J. K. Drinko, M. Martin, et al. Impact of left ventricular outflow tract area on systolic outflow velocity in hypertrophic cardiomyopathy: A real-time three-dimensional echocardiographic study J. Am. Coll. Cardiol., January 16, 2002; 39(2): 308 - 314. [Abstract] [Full Text] [PDF]

				J. Xin, T. Shiota, H. M. Lever, S. R. Kapadia, M. Sitges, D. N. Rubin, F. Bauer, N. L. Greenberg, D. A. Agler, J. K. Drinko, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1994 - 2000. [Abstract] [Full Text] [PDF]

				S. F. Nagueh, S. R. Ommen, N. M. Lakkis, D. Killip, W. A. Zoghbi, H. V. Schaff, G. K. Danielson, M. A. Quinones, A. J. Tajik, and W. H. Spencer III Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1701 - 1706. [Abstract] [Full Text] [PDF]

				S. F. Nagueh, S. J. Stetson, N. M. Lakkis, D. Killip, A. Perez-Verdia, M. L. Entman, W. H. Spencer III, and G. Torre-Amione Decreased Expression of Tumor Necrosis Factor-{{alpha}} and Regression of Hypertrophy After Nonsurgical Septal Reduction Therapy for Patients With Hypertrophic Obstructive Cardiomyopathy Circulation, April 10, 2001; 103(14): 1844 - 1850. [Abstract] [Full Text] [PDF]

				W. Mazur, S. F. Nagueh, N. M. Lakkis, K. J. Middleton, D. Killip, R. Roberts, and W. H. Spencer III Regression of Left Ventricular Hypertrophy After Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy Circulation, March 20, 2001; 103(11): 1492 - 1496. [Abstract] [Full Text] [PDF]

				R. Flores-Ramirez, N. M. Lakkis, K. J. Middleton, D. Killip, W. H. Spencer III, and S. F. Nagueh Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy J. Am. Coll. Cardiol., January 1, 2001; 37(1): 208 - 214. [Abstract] [Full Text] [PDF]

				E. H. C. Yu, A. S. Omran, E. D. Wigle, W. G. Williams, S. C. Siu, and H. Rakowski Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2219 - 2225. [Abstract] [Full Text] [PDF]

				M. V. Sherrid, D. Z. Gunsburg, S. Moldenhauer, and G. Pearle Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1344 - 1354. [Abstract] [Full Text] [PDF]

				S. F. Nagueh, N. M. Lakkis, K. J. Middleton, D. Killip, W. A. Zoghbi, M. A. Quinones, and W. H. Spencer III Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1123 - 1128. [Abstract] [Full Text] [PDF]

				D. A. Kass, C.-H. Chen, M. W. Talbot, C. E. Rochitte, J. A. C. Lima, R. D. Berger, and H. Calkins Ventricular Pacing With Premature Excitation for Treatment of Hypertensive-Cardiac Hypertrophy With Cavity-Obliteration Circulation, August 24, 1999; 100(8): 807 - 812. [Abstract] [Full Text] [PDF]

				S. R. Ommen, R. A. Nishimura, R. W. Squires, H. V. Schaff, G. K. Danielson, and A. J. Tajik Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: A comparison of objective hemodynamic and exercise end points J. Am. Coll. Cardiol., July 1, 1999; 34(1): 191 - 196. [Abstract] [Full Text] [PDF]

				P. Spirito, C. Rapezzi, P. Bellone, S. Betocchi, C. Autore, M. R. Conte, G. P. Bezante, and P. Bruzzi Infective Endocarditis in Hypertrophic Cardiomyopathy : Prevalence, Incidence, and Indications for Antibiotic Prophylaxis Circulation, April 27, 1999; 99(16): 2132 - 2137. [Abstract] [Full Text] [PDF]

				S. F. Nagueh, N. M. Lakkis, K. J. Middleton, D. Killip, W. A. Zoghbi, M. A. Quinones, and W. H. Spencer Changes in Left Ventricular Diastolic Function 6 Months After Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy Circulation, January 26, 1999; 99(3): 344 - 347. [Abstract] [Full Text] [PDF]

				J. P. Murgo Systolic ejection murmurs in the era of modern cardiology: What do we really know? J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1596 - 1602. [Abstract] [Full Text] [PDF]

				N. M. Lakkis, S. F. Nagueh, N. S. Kleiman, D. Killip, Z.-X. He, M. S. Verani, R. Roberts, and W. H. Spencer III Echocardiography-Guided Ethanol Septal Reduction for Hypertrophic Obstructive Cardiomyopathy Circulation, October 27, 1998; 98(17): 1750 - 1755. [Abstract] [Full Text] [PDF]

				S. F. Nagueh, N. M. Lakkis, Z.-X. He, K. J. Middleton, D. Killip, W. A. Zoghbi, M. A. Quinones, R. Roberts, M. S. Verani, N. S. Kleiman, et al. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy J. Am. Coll. Cardiol., July 1, 1998; 32(1): 225 - 229. [Abstract] [Full Text] [PDF]

				A. M. Kizilbash, S. K. Heinle, and P. A. Grayburn Spontaneous Variability of Left Ventricular Outflow Tract Gradient in Hypertrophic Obstructive Cardiomyopathy Circulation, February 10, 1998; 97(5): 461 - 466. [Abstract] [Full Text] [PDF]

				M. V. Sherrid, G. Pearle, and D. Z. Gunsburg Mechanism of Benefit of Negative Inotropes in Obstructive Hypertrophic Cardiomyopathy Circulation, January 13, 1998; 97(1): 41 - 47. [Abstract] [Full Text] [PDF]

				M. Hamada, Y. Shigematsu, S. Ikeda, Y. Hara, H. Okayama, K. Kodama, T. Ochi, and K. Hiwada Class Ia Antiarrhythmic Drug Cibenzoline : A New Approach to the Medical Treatment of Hypertrophic Obstructive Cardiomyopathy Circulation, September 2, 1997; 96(5): 1520 - 1524. [Abstract] [Full Text]

				J. Bartunek, S. U. Sys, A. C. Rodrigues, E. Van Schuerbeeck, L. Mortier, and B. de Bruyne Abnormal Systolic Intraventricular Flow Velocities After Valve Replacement for Aortic Stenosis : Mechanisms, Predictive Factors, and Prognostic Significance Circulation, February 15, 1996; 93(4): 712 - 719. [Abstract] [Full Text]

				P. R. Fox, S.-K. Liu, and B. J. Maron Echocardiographic Assessment of Spontaneously Occurring Feline Hypertrophic Cardiomyopathy : An Animal Model of Human Disease Circulation, November 1, 1995; 92(9): 2645 - 2651. [Abstract] [Full Text]

				R. A. Levine, G. J. Vlahakes, X. Lefebvre, J. L. Guerrero, E. G. Cape, A. P. Yoganathan, and A. E. Weyman Papillary Muscle Displacement Causes Systolic Anterior Motion of the Mitral Valve : Experimental Validation and Insights Into the Mechanism of Subaortic Obstruction Circulation, February 15, 1995; 91(4): 1189 - 1195. [Abstract] [Full Text]